MacroGenics logo
MacroGenics MGNX
€ 1.18 -1.42%

Quartalsbericht 2025-Q3
hinzugefügt 12.11.2025

report update icon

MacroGenics DSO 2011-2025 | MGNX

DSO Jährlich MacroGenics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
207 80 78.9 62.3 72.5 180 31.6 11 4.43 22.4 12.6 - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
207 4.43 69.3

DSO Vierteljährlich MacroGenics

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
51.2 47.3 51.4 - 6.16 - - - 139 148 172 - 35.2 58.4 104 - 172 77.7 81.7 - 115 104 119 46.2 62 110 200 171 130 143 420 8.17 749 747 364 49.4 77.5 3.13 63.9 13.7 7.61 16.6 2.66 48.9 14.6 29.1 15.3 12.3 9.04 7.43 8.81 19.1 5.81 - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
749 2.66 110

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
132 $ 220.27 4.81 % $ 5 B danmarkDanmark
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 0.28 -2.28 % $ 609 M israelIsrael
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
16.2 K $ 3.3 -3.51 % $ 7.94 B australiaAustralia
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Aptorum Group Limited Aptorum Group Limited
APM
20.6 $ 1.29 -3.01 % $ 7.03 M chinaChina
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
31.5 $ 4.75 1.61 % $ 788 M canadaCanada
Aclaris Therapeutics Aclaris Therapeutics
ACRS
6.01 $ 3.26 -3.12 % $ 252 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
25 - -15.15 % $ 60.3 M britainBritain
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
14.7 - -0.23 % $ 916 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
62.6 $ 25.27 -2.43 % $ 1.22 B usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
77.3 $ 9.57 0.84 % $ 140 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
946 - -6.81 % $ 3.04 B usaUSA
Athersys Athersys
ATHX
22.6 - 3.77 % $ 22.4 M usaUSA
Axon Enterprise Axon Enterprise
AXON
134 $ 566.18 -2.56 % $ 42.9 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
150 $ 2.34 2.59 % $ 14.7 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
Brickell Biotech Brickell Biotech
BBI
254 - -5.38 % $ 6.06 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
49.5 - 0.49 % $ 251 B cayman-islandsCayman-islands
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
169 $ 11.54 0.87 % $ 746 M usaUSA
Biogen Biogen
BIIB
57.9 $ 174.42 1.11 % $ 25.4 B usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
387 $ 5.36 -2.99 % $ 115 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
56.5 $ 10.85 -0.14 % $ 1.41 B usaUSA
ADiTx Therapeutics ADiTx Therapeutics
ADTX
621 $ 2.3 -3.0 % $ 30.3 K usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
6.09 - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
103 - -7.31 % $ 87 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Фармсинтез Фармсинтез
LIFE
209 - - - russiaRussia
bluebird bio bluebird bio
BLUE
2.47 - - $ 546 M usaUSA